[Human chorionic gonadotropin: a feasible option for treating undescended testes].
In order to shed light on the controversy in the literature about the efficacy of medical treatment of undescended testes, HCG was administered to 73 boys. They were seven month to twelve years old and none of them had puberty signs. Cryptorchidism was unilateral in 75.4%; it was bilateral in 24.6%. Children with retractile testes were excluded from the study. The patients received IM HCG 1500 to 2000 IU/sqm twice a week for 5 weeks. Testicular descent was noted in 23.0% of the undescended testes, often in the first 2.5 weeks of therapy. All children were followed up for at least a year and relapse was observed in 8.3%. Clinical signs of testosterone action faded off shortly after the end of injections. No side effects were apparent by the third month after treatment. We conclude that the administration of HCG is worth of a trial before the surgical approach is contemplated in the management of the cryptorchidism.
Chagas
A J
AJ
Depto. de Pediatria da Universidade Federal de minas Gerais (UFMG), Belo Horizonte, MG, Brazil.
Silva
I N
IN
Oliveira
D F
DF